These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35225027)

  • 41. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Danshensu prevents hypoxic pulmonary hypertension in rats by inhibiting the proliferation of pulmonary artery smooth muscle cells via TGF-β-smad3-associated pathway.
    Zhang N; Dong M; Luo Y; Zhao F; Li Y
    Eur J Pharmacol; 2018 Feb; 820():1-7. PubMed ID: 29221952
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long Noncoding RNA Rps4l Mediates the Proliferation of Hypoxic Pulmonary Artery Smooth Muscle Cells.
    Liu Y; Zhang H; Li Y; Yan L; Du W; Wang S; Zheng X; Zhang M; Zhang J; Qi J; Sun H; Zhang L; Li G; Zhu D
    Hypertension; 2020 Oct; 76(4):1124-1133. PubMed ID: 32772647
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CPT1 regulates the proliferation of pulmonary artery smooth muscle cells through the AMPK-p53-p21 pathway in pulmonary arterial hypertension.
    Zhuang W; Lian G; Huang B; Du A; Gong J; Xiao G; Xu C; Wang H; Xie L
    Mol Cell Biochem; 2019 May; 455(1-2):169-183. PubMed ID: 30511343
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RAS protein activator like 2 promotes the proliferation and migration of pulmonary artery smooth muscle cell through AKT/mammalian target of Rapamycin complex 1 pathway in pulmonary hypertension.
    Hu S; Zhao Y; Qiu C; Li Y
    Bioengineered; 2022 Feb; 13(2):3516-3526. PubMed ID: 35044284
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LRP1 Deficiency in Vascular SMC Leads to Pulmonary Arterial Hypertension That Is Reversed by PPARγ Activation.
    Calvier L; Boucher P; Herz J; Hansmann G
    Circ Res; 2019 Jun; 124(12):1778-1785. PubMed ID: 31023188
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-apoptosis endothelial cell-secreted microRNA-195-5p promotes pulmonary arterial smooth muscle cell proliferation and migration in pulmonary arterial hypertension.
    Zeng Z; Yao J; Li Y; Xue Y; Zou Y; Shu Z; Jiao Z
    J Cell Biochem; 2018 Feb; 119(2):2144-2155. PubMed ID: 28862358
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Upregulated expression of STIM2, TRPC6, and Orai2 contributes to the transition of pulmonary arterial smooth muscle cells from a contractile to proliferative phenotype.
    Fernandez RA; Wan J; Song S; Smith KA; Gu Y; Tauseef M; Tang H; Makino A; Mehta D; Yuan JX
    Am J Physiol Cell Physiol; 2015 Apr; 308(8):C581-93. PubMed ID: 25673771
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Implication of Inflammation and Epigenetic Readers in Coronary Artery Remodeling in Patients With Pulmonary Arterial Hypertension.
    Meloche J; Lampron MC; Nadeau V; Maltais M; Potus F; Lambert C; Tremblay E; Vitry G; Breuils-Bonnet S; Boucherat O; Charbonneau E; Provencher S; Paulin R; Bonnet S
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1513-1523. PubMed ID: 28473439
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Notch3 signaling activation in smooth muscle cells promotes extrauterine growth restriction-induced pulmonary hypertension.
    Wang Y; Dai S; Cheng X; Prado E; Yan L; Hu J; He Q; Lv Y; Lv Y; Du L
    Nutr Metab Cardiovasc Dis; 2019 Jun; 29(6):639-651. PubMed ID: 30954415
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced Ca(2+)-sensing receptor function in idiopathic pulmonary arterial hypertension.
    Yamamura A; Guo Q; Yamamura H; Zimnicka AM; Pohl NM; Smith KA; Fernandez RA; Zeifman A; Makino A; Dong H; Yuan JX
    Circ Res; 2012 Aug; 111(4):469-81. PubMed ID: 22730443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Involvement of Gax gene in hypoxia-induced pulmonary hypertension, proliferation, and apoptosis of arterial smooth muscle cells.
    Xia S; Tai X; Wang Y; An X; Qian G; Dong J; Wang X; Sha B; Wang D; Murthi P; Kalionis B; Wang X; Bai C
    Am J Respir Cell Mol Biol; 2011 Jan; 44(1):66-73. PubMed ID: 20160044
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nur77 downregulation triggers pulmonary artery smooth muscle cell proliferation and migration in mice with hypoxic pulmonary hypertension via the Axin2-β-catenin signaling pathway.
    Nie X; Tan J; Dai Y; Mao W; Chen Y; Qin G; Li G; Shen C; Zhao J; Chen J
    Vascul Pharmacol; 2016 Dec; 87():230-241. PubMed ID: 27871853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment.
    Veith C; Zakrzewicz D; Dahal BK; Bálint Z; Murmann K; Wygrecka M; Seeger W; Schermuly RT; Weissmann N; Kwapiszewska G
    Thromb Haemost; 2014 Dec; 112(6):1288-303. PubMed ID: 25231004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PAR-2 inhibition reverses experimental pulmonary hypertension.
    Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
    Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A modified Fangji Huangqi decoction ameliorates pulmonary artery hypertension via phosphatidylinositide 3-kinases/protein kinase B-mediated regulation of proliferation and apoptosis of smooth muscle cells in vitro and in vivo.
    Xue Z; Zhou M; Liu Y; Qin H; Li Y; Zhu Y; Yang J
    J Ethnopharmacol; 2023 Oct; 314():116544. PubMed ID: 37088239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of Cell Cycle Regulators by SIRT1 Contributes to Resveratrol-Mediated Prevention of Pulmonary Arterial Hypertension.
    Zhou S; Li MT; Jia YY; Liu JJ; Wang Q; Tian Z; Liu YT; Chen HZ; Liu DP; Zeng XF
    Biomed Res Int; 2015; 2015():762349. PubMed ID: 26273643
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle.
    Paffett ML; Lucas SN; Campen MJ
    Vascul Pharmacol; 2012; 56(1-2):64-73. PubMed ID: 22146233
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methylation-mediated silencing of PTPRD induces pulmonary hypertension by promoting pulmonary arterial smooth muscle cell migration via the PDGFRB/PLCγ1 axis.
    Xu J; Zhong Y; Yin H; Linneman J; Luo Y; Xia S; Xia Q; Yang L; Huang X; Kang K; Wang J; Niu Y; Li L; Gou D
    J Hypertens; 2022 Sep; 40(9):1795-1807. PubMed ID: 35848503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.